Log In
Print this Print this

Revlimid, lenalidomide (formerly CDC 501)

Also known as: CC-5013

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionThalidomide analog
Molecular Target Unknown
Mechanism of ActionImmune modulation
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today